{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:08:19Z","timestamp":1792872499753,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104469"],"award-info":[{"award-number":["82104469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["cstc2021jcyj-bshX0161"],"award-info":[{"award-number":["cstc2021jcyj-bshX0161"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0470"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0470"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jep.2025.119358","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T18:19:56Z","timestamp":1736619596000},"page":"119358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cepharanthine relieves nonalcoholic steatohepatitis through inhibiting STAT1\/CXCL10 axis-mediated lipogenesis and inflammatory responses"],"prefix":"10.1016","volume":"341","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7148-1962","authenticated-orcid":false,"given":"Pan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0278-385X","authenticated-orcid":false,"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.22435","article-title":"Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States","volume":"18","author":"Afzali","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.jep.2025.119358_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.767314","article-title":"Current and potential therapies targeting inflammation in nash","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: aurora phase iii randomized study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2025.119358_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: an update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.jep.2025.119358_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and nash in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.1300344","article-title":"Synergistic expression of the cxcl10 gene in response to il-1beta and ifn-gamma involves nf-kappab, phosphorylation of stat1 at tyr701, and acetylation of histones h3 and h4","volume":"191","author":"Burke","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of ikk-beta and nf-kappab","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020753","article-title":"Cepharanthine ameliorates pulmonary fibrosis by inhibiting the nf-kappab\/nlrp3 pathway, fibroblast-to-myofibroblast transition and inflammation","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib9","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1080\/13880209.2017.1328446","article-title":"Determination of cepharanthine in rat plasma by lc-ms\/ms and its application to a pharmacokinetic study","volume":"55","author":"Deng","year":"2017","journal-title":"Pharm. Biol."},{"issue":"3","key":"10.1016\/j.jep.2025.119358_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jep.2014.04.024","article-title":"Ethnobotany, phytochemistry and pharmacology of stephania rotunda lour","volume":"154","author":"Desgrouas","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2025.119358_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-3-319-48382-5_19","article-title":"Non-alcoholic fatty liver disease","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.jep.2025.119358_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070678","article-title":"Lxralpha regulates hepatic chrebpalpha activity and lipogenesis upon glucose, but not fructose feeding in mice","volume":"9","author":"Fan","year":"2017","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.jep.2025.119358_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep4.1079","article-title":"Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: facilitating development approaches for an emerging epidemic","volume":"1","author":"Filozof","year":"2017","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000335","article-title":"Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis","volume":"8","author":"Francque","year":"2024","journal-title":"Hepatol. Commun."},{"issue":"7","key":"10.1016\/j.jep.2025.119358_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of nafld development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.jep.2025.119358_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12906-023-03903-2","article-title":"Protective effecs of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting nlrp3\/caspase-1\/il-1beta signaling pathway","volume":"23","author":"Guan","year":"2023","journal-title":"Bmc Complement. Med. Ther."},{"issue":"5","key":"10.1016\/j.jep.2025.119358_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.14492","article-title":"Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis","volume":"47","author":"Hameed","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jep.2025.119358_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.jep.2025.119358_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in nash drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib21","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cr.2011.13","article-title":"Nf-kappab in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.jep.2025.119358_bib23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","article-title":"Liver x receptor in cooperation with srebp-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease","volume":"38","author":"Higuchi","year":"2008","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.jep.2025.119358_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1507\/endocrj.K07E-110","article-title":"Chrebp: a glucose-activated transcription factor involved in the development of metabolic syndrome","volume":"55","author":"Iizuka","year":"2008","journal-title":"Endocr. J."},{"issue":"12","key":"10.1016\/j.jep.2025.119358_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121545","article-title":"Pin1 plays essential roles in nash development by modulating multiple target proteins","volume":"8","author":"Inoue","year":"2019","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.jep.2025.119358_bib26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jsps.2022.09.013","article-title":"Cepharanthine action in preventing obesity and hyperlipidemia in rats on a high-fat high sucrose diet","volume":"30","author":"Iqbal","year":"2022","journal-title":"Saudi Pharmaceut. J."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ecl.2022.06.007","article-title":"Nonalcoholic fatty liver disease","volume":"52","author":"Isaacs","year":"2023","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.jep.2025.119358_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/504061","article-title":"Salutary effects of cepharanthine against skeletal muscle and kidney injuries following limb ischemia\/reperfusion","volume":"2015","author":"Kao","year":"2015","journal-title":"Evid.-Based Complement Altern. Med."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.jep.2025.119358_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155287","article-title":"Ginsenoside rg5 inhibits lipid accumulation and hepatocyte apoptosis via the notch1 signaling pathway in nash mice","volume":"124","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.119358_bib32","article-title":"Baicalein prevents fructose-induced hepatic steatosis in rats: in the regulation of fatty acid de novo synthesis, fatty acid elongation and fatty acid oxidation","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2025.119358_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153550","article-title":"Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats","volume":"85","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"issue":"24","key":"10.1016\/j.jep.2025.119358_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248933","article-title":"Pharmacological effects and clinical prospects of cepharanthine","volume":"27","author":"Liang","year":"2022","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.jep.2025.119358_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135019","article-title":"Pharmacological activity of cepharanthine","volume":"28","author":"Liu","year":"2023","journal-title":"Molecules"},{"issue":"195","key":"10.1016\/j.jep.2025.119358_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2003.195.re13","article-title":"The ins and outs of stat1 nuclear transport","volume":"2003","author":"Mcbride","year":"2003","journal-title":"Sci. STKE"},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3803\/EnM.2017.32.1.6","article-title":"The scap\/srebp pathway: a mediator of hepatic steatosis","volume":"32","author":"Moon","year":"2017","journal-title":"Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jep.2025.119358_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(97)00015-4","article-title":"The immunobiology of interferon-gamma inducible protein 10 kd (ip-10): a novel, pleiotropic member of the c-x-c chemokine superfamily","volume":"8","author":"Neville","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.2001.01391.x","article-title":"Increase of chemokine interferon-inducible protein-10 (ip-10) in the serum of patients with autoimmune liver diseases and increase of its mrna expression in hepatocytes","volume":"123","author":"Nishioji","year":"2001","journal-title":"Clin. Exp. Immunol."},{"issue":"10290","key":"10.1016\/j.jep.2025.119358_bib40","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jep.2025.119358_bib41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41574-023-00809-4","article-title":"The role of chrebp in carbohydrate sensing and nafld development","volume":"19","author":"Regnier","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1734-1140(11)70500-X","article-title":"Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions","volume":"63","author":"Rogosnitzky","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"8","key":"10.1016\/j.jep.2025.119358_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.medcli.2022.06.017","article-title":"Non-alcoholic steatohepatitis","volume":"159","author":"Romero-Gomez","year":"2022","journal-title":"Med. Clin."},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.jep.2025.119358_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2009.01.003","article-title":"Cxcl10 impairs beta cell function and viability in diabetes through tlr4 signaling","volume":"9","author":"Schulthess","year":"2009","journal-title":"Cell Metabol."},{"issue":"12","key":"10.1016\/j.jep.2025.119358_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jep.2025.119358_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144444","article-title":"The signal transducer and activator of transcription 1 (stat1) inhibits mitochondrial biogenesis in liver and fatty acid oxidation in adipocytes","volume":"10","author":"Sisler","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jep.2025.119358_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"Nf-kappab: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"42","key":"10.1016\/j.jep.2025.119358_bib49","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.jep.2025.119358_bib50","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/jcb.25973","article-title":"Mixed lineage kinase 3 mediates the induction of cxcl10 by a stat1-dependent mechanism during hepatocyte lipotoxicity","volume":"118","author":"Tomita","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jep.2025.119358_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115248","article-title":"Alkaloids in genus stephania (menispermaceae): a comprehensive review of its ethnopharmacology, phytochemistry, pharmacology and toxicology","volume":"293","author":"Wang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2025.119358_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.704704","article-title":"Comprehensive analysis of nafld and the therapeutic target identified","volume":"9","author":"Wen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jep.2025.119358_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116908","article-title":"A novel alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of pparalpha signaling pathway","volume":"176","author":"Xie","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2025.119358_bib54","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/erm.2016.16","article-title":"C-x-c motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication","volume":"18","author":"Xu","year":"2016","journal-title":"Expet Rev. Mol. Med."},{"issue":"10215","key":"10.1016\/j.jep.2025.119358_bib55","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jep.2025.119358_bib56","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/hep.22500","article-title":"Intrahepatic levels of cxcr3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis c","volume":"48","author":"Zeremski","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jep.2025.119358_bib57","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"Cxcl10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.jep.2025.119358_bib58","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.7150\/thno.19068","article-title":"C-x-c motif chemokine 10 impairs autophagy and autolysosome formation in non-alcoholic steatohepatitis","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"}],"updated-by":[{"DOI":"10.1016\/j.jep.2025.119767","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000}}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:57:52Z","timestamp":1762307872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874125000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":58,"alternative-id":["S0378874125000418"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2025.119358","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cepharanthine relieves nonalcoholic steatohepatitis through inhibiting STAT1\/CXCL10 axis-mediated lipogenesis and inflammatory responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2025.119358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119358"}}